ArticleVirus research2026

An IMS 1313-based inactivated PRV vaccine with a novel immunopotentiator induces robust protective immunity against virulent variants.

Ya-Ting Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.